Year archive

SynAct Pharma — 2022 filings

All 16 regulatory filings released by SynAct Pharma (SYNACT) in 2022, sourced directly from the official regulator.

16 Filings

2022 Period

2022 filings (16)

Filing	Released	Lang
Change in number of shares and votes in SynAct Pharma Declaration of Voting Results & Voting Rights Announcements	2022-12-30	English
Ändring av antalet aktier och röster i SynAct Pharma Declaration of Voting Results & Voting Rights Announcements	2022-12-30	Swedish
Ändring i valberedning inför årsstämma 2023 i SynAct Pharma Governance Information	2022-12-22	Swedish
Change in Nomination Committee prior to AGM 2023 in SynAct Pharma AGM Information	2022-12-22	English
Kallelse till extra bolagsstämma i SynAct Pharma AB AGM Information	2022-12-12	Swedish
Notice of extraordinary general meeting in SynAct Pharma AB AGM Information	2022-12-12	English
SynAct Pharma carries out a directed share issue of SEK 80 million in connection with the acquisition of TXP Pharma Share Issue/Capital Change	2022-12-12	English
SynAct Pharma genomför en riktad nyemission om 80 miljoner kronor med anledning av förvärvet av TXP Pharma Share Issue/Capital Change	2022-12-12	Swedish
SynAct Pharma to make strategic acquisition of Swiss biotech company TXP Pharma M&A Activity	2022-12-12	English
SynAct Pharma planerar strategiskt förvärv av det schweiziska bioteknikbolaget TXP Pharma M&A Activity	2022-12-12	Swedish
Interim / Quarterly Report 2022 Interim / Quarterly Report Q3 2022	2022-11-04	Swedish
Interim / Quarterly Report 2022 Interim / Quarterly Report Q3 2022	2022-11-04	English
Valberedning utsedd inför årsstämma 2023 i SynAct Pharma AB AGM Information	2022-10-21	Swedish
Nomination Committee appointed ahead of AGM 2023 in SynAct Pharma AB AGM Information	2022-10-21	English
Interim / Quarterly Report 2022 Interim / Quarterly Report Q2 2022	2022-08-05	Swedish
Interim / Quarterly Report 2022 Interim / Quarterly Report Q2 2022	2022-08-05	English